MAETZOLD DEREK J sold CSTL

August 28, 2026 · Form 4 insider transaction

MAETZOLD DEREK J sold 11,472 shares of Castle Biosciences, Inc. at $33.14 per share, a transaction worth $380.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
11,472
Price
$33.14
Total value
$380.2K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 28, 2026
Filing dateSeptember 1, 2026
Shares owned after22,435
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 3, 2025.; This transaction was executed in multiple trades at prices ranging from $32.78 to $33.70, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
MAETZOLD DEREK J sold CSTL: August 28, 2026 | Insider Trading Screener